The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype
Stephanie C. M. Nijmeijer(Amsterdam University Medical Centers), Margreet A. E. M. Wagenmakers(Erasmus MC), Anneke J.A. Kievit(Erasmus MC), Susanne Roosing(Radboud University Nijmegen), Janneke G. Langendonk(Erasmus MC), Jan Pieter Marchal(Amsterdam University Medical Centers), Karolina M. Stępień(Medical University of Warsaw), L.I. van den Born(Rotterdam Eye Hospital), Frits A. Wijburg(Emma Kinderziekenhuis)
Cited by 47
Related Papers
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
|Proceedings of the National Academy of Sciences|2008|725
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update
|Molecular Genetics and Metabolism|2012|478
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study
|Journal of the American Society of Nephrology|2016|421
Sanfilippo syndrome: A mini‐review
|Journal of Inherited Metabolic Disease|2008|401